RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells

Angiogenesis is a hallmark of cancer cell malignancy. The role of the RHO family GTPase RHOG in angiogenesis in vascular endothelial cells has recently been elucidated. However, the regulation of RHOG during this process, as well as its cross-talk with other RHO GTPases, have yet to be fully examine...

Full description

Bibliographic Details
Main Authors: Oula El Atat, Amira Fakih, Mirvat El-Sibai
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/8/2/171
_version_ 1827885203775815680
author Oula El Atat
Amira Fakih
Mirvat El-Sibai
author_facet Oula El Atat
Amira Fakih
Mirvat El-Sibai
author_sort Oula El Atat
collection DOAJ
description Angiogenesis is a hallmark of cancer cell malignancy. The role of the RHO family GTPase RHOG in angiogenesis in vascular endothelial cells has recently been elucidated. However, the regulation of RHOG during this process, as well as its cross-talk with other RHO GTPases, have yet to be fully examined. In this study, we found that siRNA-mediated depletion of RHOG strongly inhibits tube formation in vascular endothelial cells (ECV cells), an effect reversed by transfecting dominant active constructs of CDC42 or RAC1 in the RHOG-depleted cells. We also found CDC42 to be upstream from RAC1 in these cells. Inhibiting either Phosphatidyl inositol (3) kinase (PI3K) with Wortmannin or the mitogen-activated protein kinase extracellular-regulated kinase (MAPK ERK) with U0126 leads to the inhibition of tube formation. While knocking down either RHO, GTPase did not affect p-AKT levels, and p-ERK decreased in response to the knocking down of RHOG, CDC42 or RAC1. Recovering active RHO GTPases in U0126-treated cells also did not reverse the inhibition of tube formation, placing ERK downstream from PI3K-RHOG-CDC42-RAC1 in vascular endothelial cells. Finally, RHOA and the Rho activated protein kinases ROCK1 and ROCK2 positively regulated tube formation independently of ERK, while RHOC seemed to inhibit the process. Collectively, our data confirmed the essential role of RHOG in angiogenesis, shedding light on a potential new therapeutic target for cancer malignancy and metastasis.
first_indexed 2024-03-12T19:42:27Z
format Article
id doaj.art-8fc85de4d8d0450795c3926fb1a2b660
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T19:42:27Z
publishDate 2019-02-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-8fc85de4d8d0450795c3926fb1a2b6602023-08-02T03:46:58ZengMDPI AGCells2073-44092019-02-018217110.3390/cells8020171cells8020171RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial CellsOula El Atat0Amira Fakih1Mirvat El-Sibai2Department of Natural Sciences, Lebanese American University, Beirut 1102 2801, LebanonDepartment of Natural Sciences, Lebanese American University, Beirut 1102 2801, LebanonDepartment of Natural Sciences, Lebanese American University, Beirut 1102 2801, LebanonAngiogenesis is a hallmark of cancer cell malignancy. The role of the RHO family GTPase RHOG in angiogenesis in vascular endothelial cells has recently been elucidated. However, the regulation of RHOG during this process, as well as its cross-talk with other RHO GTPases, have yet to be fully examined. In this study, we found that siRNA-mediated depletion of RHOG strongly inhibits tube formation in vascular endothelial cells (ECV cells), an effect reversed by transfecting dominant active constructs of CDC42 or RAC1 in the RHOG-depleted cells. We also found CDC42 to be upstream from RAC1 in these cells. Inhibiting either Phosphatidyl inositol (3) kinase (PI3K) with Wortmannin or the mitogen-activated protein kinase extracellular-regulated kinase (MAPK ERK) with U0126 leads to the inhibition of tube formation. While knocking down either RHO, GTPase did not affect p-AKT levels, and p-ERK decreased in response to the knocking down of RHOG, CDC42 or RAC1. Recovering active RHO GTPases in U0126-treated cells also did not reverse the inhibition of tube formation, placing ERK downstream from PI3K-RHOG-CDC42-RAC1 in vascular endothelial cells. Finally, RHOA and the Rho activated protein kinases ROCK1 and ROCK2 positively regulated tube formation independently of ERK, while RHOC seemed to inhibit the process. Collectively, our data confirmed the essential role of RHOG in angiogenesis, shedding light on a potential new therapeutic target for cancer malignancy and metastasis.https://www.mdpi.com/2073-4409/8/2/171RHOGRAC1CDC42RHO GTPasesangiogenesisvascular endothelial cells
spellingShingle Oula El Atat
Amira Fakih
Mirvat El-Sibai
RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells
Cells
RHOG
RAC1
CDC42
RHO GTPases
angiogenesis
vascular endothelial cells
title RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells
title_full RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells
title_fullStr RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells
title_full_unstemmed RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells
title_short RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells
title_sort rhog activates rac1 through cdc42 leading to tube formation in vascular endothelial cells
topic RHOG
RAC1
CDC42
RHO GTPases
angiogenesis
vascular endothelial cells
url https://www.mdpi.com/2073-4409/8/2/171
work_keys_str_mv AT oulaelatat rhogactivatesrac1throughcdc42leadingtotubeformationinvascularendothelialcells
AT amirafakih rhogactivatesrac1throughcdc42leadingtotubeformationinvascularendothelialcells
AT mirvatelsibai rhogactivatesrac1throughcdc42leadingtotubeformationinvascularendothelialcells